E-LIB Suche - Ergebnisse für: Neal-Perry, Genevieve

1

Sleep Health and Anxiety Symptoms in Midlife Women: The Stu..:

Kravitz, Howard ; Ruppert, Kristine ; Lian, Pam..
International Journal of Women's Health. 16 (2024) - p. 1079-1091 , 2024

Link: https://doi.org/10.2147/..

2

Disparities in menopausal care in the United States: A syst..:

Zahn, Katelin ; Pittman, Allison ; Conklin, Jamie..
Maturitas. 186 (2024) - p. 108021 , 2024

Link: https://doi.org/10.1016/..

3

Totality of evidence refutes neoplasm risk with fezolinetan:

Neal-Perry, Genevieve ; Santoro, Nanette ; Cano, Antonio...
The Lancet. 403 (2024) 10440 - p. 1987-1988 , 2024

Link: https://doi.org/10.1016/..

4

Fezolinetant treatment of moderate-to-severe vasomotor symp..:

Santoro, Nanette ; Nappi, Rossella E. ; Neal-Perry, Genevieve...
Menopause. 31 (2024) 4 - p. 247-257 , 2024

Link: https://doi.org/10.1097/..

5

Ex ovo omnia—why don't we know more about egg quality via i..:

Boylan, Caitlin F ; Sambo, Keshia M ; Neal-Perry, Genevieve.
Biology of Reproduction. 110 (2024) 6 - p. 1201-1212 , 2024

Link: https://doi.org/10.1093/..

6

Early response with fezolinetant treatment of moderate-to-s..:

Shapiro, Marla ; Neal-Perry, Genevieve ; Stute, Petra...
Maturitas. 173 (2023) - p. 74 , 2023

Link: https://doi.org/10.1016/..

7

Safety of Fezolinetant for Vasomotor Symptoms Associated Wi..:

Neal-Perry, Genevieve ; Cano, Antonio ; Lederman, Samuel...
Obstetrics & Gynecology. 141 (2023) 4 - p. 737-747 , 2023

Link: https://doi.org/10.1097/..

8

Single-visit insertion of long-acting reversible contracept..:

Stuart, Gretchen S. ; Yates, Lindsey ; Crump, Johanna...
Contraception. 123 (2023) - p. 110009 , 2023

Link: https://doi.org/10.1016/..

9

Fezolinetant Treatment of Moderate-to-Severe Vasomotor Symp..:

Santoro, Nanette ; King, Deanna ; Nappi, Rossella...
Obstetrics & Gynecology. 141 (2023) 5S - p. 12S-12S , 2023

Link: https://doi.org/10.1097/..

10

Sleep timing, sleep regularity, and psychological health in..:

Swanson, Leslie M. ; Hood, Michelle M. ; Hall, Martica H....
Sleep Health. 9 (2023) 2 - p. 203-210 , 2023

Link: https://doi.org/10.1016/..

11

Efficacy and Safety of Fezolinetant in Moderate to Severe V..:

Johnson, Kimball A ; Martin, Nancy ; Nappi, Rossella E...
The Journal of Clinical Endocrinology & Metabolism. 108 (2023) 8 - p. 1981-1997 , 2023

Link: https://doi.org/10.1210/..

12

Fezolinetant for treatment of moderate-to-severe vasomotor ..:

Lederman, Samuel ; Ottery, Faith D ; Cano, Antonio...
The Lancet. 401 (2023) 10382 - p. 1091-1102 , 2023

Link: https://doi.org/10.1016/..

13

Phase 3 Study of Fezolinetant for Treatment of Moderate-to-..:

Lederman, Samuel ; Shapiro CM, Marla ; Stute, Petra...
Obstetrics & Gynecology. 139 (2022) 1 - p. 39S-39S , 2022

Link: https://doi.org/10.1097/..

14

OR06-5 Fezolinetant for Treatment of Moderate-to-severe Vas..:

English, Marci ; Franklin, Catherine ; Johnson, Kimball...
Journal of the Endocrine Society. 6 (2022) Supplement_1 - p. A678-A679 , 2022

Link: https://doi.org/10.1210/..

15

Patterns of Sexual Activity and the Development of Sexual P..:

Waetjen, L. Elaine ; Johnson, Wesley O. ; Xing, Guibo...
Obstetrics & Gynecology. 139 (2022) 6 - p. 1130-1140 , 2022

Link: https://doi.org/10.1097/..